Prevalence and incidence of diabetes mellitus: a nationwide population‐based pharmaco‐epidemiological study in Sweden

Abstract

The prevalence of pharmacologically treated diabetes increased moderately during 8 years of follow-up, while the incidence decreased modestly. This is in contrast to the results reported by most other studies. The total prevalence of diabetes (both pharmacologically and non-pharmacologically treated) in Sweden is relatively low, from a global viewpoint.

Secular changes in cardiovascular risk factors in Swedish 50-year-old men over a 50-year period: The study of men born in 1913, 1923, 1933, 1943, 1953 and 1963

“…4 The observed increase in physical activity may contribute to explaining why the rate of diabetes did not increase despite the increase in obesity. This finding is consistent with the observation in a Swedish registry study by Jansson et al, 19 who found the prevalence of pharmacologically treated diabetes to increase moderately during 2005-2013, whereas the incidence decreased modestly. Nevertheless, it should be noted that the prevalence of diabetes and obesity was much lower than that reported in in EUROSPIRE, a large European survey of patients diagnosed with CHD.…”

Incidence, prevalence and mortality of type 2 diabetes requiring glucose-lowering treatment, and associated risks of cardiovascular complications: a nationwide study in Sweden, 2006–2013

“…A recent report from Sweden has also reported increasing diabetes prevalence, although at somewhat different rates from those described here. Jansson et al analysed the prevalence of pharmacologically treated diabetes (both type 1 and type 2 combined) during 2005 to 2013 and found on average a 27% higher prevalence and 10% higher incidence than our results showed [8]. A possible explanation for this discrepancy is that in contrast to Jansson et al, who used the PDR only, we used information from several nationwide data sources (the PDR, the Cause of Death Register and the National Patient Register) to assess diabetes diagnosis and censor patients with type 2 diabetes; this probably resulted in more accurate estimates of prevalence and incidence.…”

“…There have been several national reports on diabetes prevalence and incidence, with different findings. Some describe an increased prevalence of diabetes [8,[12][13][14][15][16][17]; the majority report a stable incidence [12,13,15,16,18], some an increasing incidence [19,20] and one a decreasing incidence [8]. Explanations for these discrepant findings could be related to the decade in which the studies were performed, the definitions applied, the type of register used and the ethnic composition of the population.…”

“…Recent figures from Sweden show that despite a rise in prevalence of obesity and of being overweight [5], both the prevalence and incidence of diabetes are unchanged [6,7] or only slightly increasing [8]. Considering the ageing population in Sweden, and that levels of physical inactivity are unchanged and obesity is increasing, this finding is unexpected [4].…”

Enhanced Differentiation of Wharton’s Jelly-Derived Mesenchymal Stem Cells in Insulin-Producing Cells by the Extract of Nigella sativa Seeds

“…According to the international diabetes federation (IDF), it is estimated that 382 million people worldwide have diabetes (2)(3)(4). Furthermore, umbilical cord and Wharton's jelly (the vessels out of the umbilical cord) are better sources for Mesenchymal stem cells (MSCs), since they are globally accessible tissues and their gathering does not lead to any ethical harm, as they are ordinarily disposed as human waste (5)(6)(7).…”